PDS Biotechnology Corporation Profile Avatar - Palmy Investing

PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment fo…

Biotechnology
US, Florham Park [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of PDSB's Analysis
CIK: 1472091 CUSIP: 70465T107 ISIN: US70465T1079 LEI: - UEI: -
Secondary Listings
PDSB has no secondary listings inside our databases.